查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1617732

高通量篩檢市場：按產品和服務、篩檢規模、技術、應用、最終用戶 - 2025-2030 年全球預測

High-Throughput Screening Market by Product & Service (Consumables, Instruments, Services), Screening Size (12-well Format, 1536-well Format, 24-well Format), Technology, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年高通量篩檢市場價值為242億美元，預計2024年將達270.1億美元，複合年成長率為12.08%，到2030年將達到537.8億美元。

高通量篩檢(HTS) 是藥物發現和化學生物學中的重要技術，有助於在細胞或分子層面上快速檢測數千至數百萬個樣本的生物活性。 HTS 主要用於識別調節特定生物分子途徑的活性化合物、抗體或基因。對 HTS 的需求源於對高效藥物發現過程日益成長的需求，使研究人員能夠從龐大的化學和遺傳材料庫中快速識別有前途的候選化合物。 HTS的應用廣泛，包括製藥、生物技術和學術研究機構，為藥物開發商、生物科學家和基因組研究人員等最終用戶提供服務。市場成長受到機器人和資料分析技術進步以及對個人化醫療和生技藥品日益成長的興趣的顯著影響。一個關鍵的機會在於擴大使用人工智慧和機器學習來增強 HTS 的資料分析能力，從而提高預測準確性並減少誤報。此外，檢測小型化和自動化的進步為降低成本和提高通量開闢了進一步的途徑。然而，高溫超導技術所需的高初始投資以及與資料管理和整合相關的複雜性等挑戰可能會限制市場成長。智慧財產權問題和監管障礙也是主要障礙。專注於生物資訊學和高溫超導整合的創新以及新型檢測技術的開發，特別是在基因組學和蛋白​​質組學領域，為業務成長提供了肥沃的土壤。在持續技術進步的推動下，市場預計將充滿活力和競爭。希望獲得市場佔有率的公司可以透過投資強大的資料分析工具並專注於合作夥伴關係關係來簡化 HTS 方法，從而在不斷發展的藥物發現和個人化醫療領域中保持領先地位。

主要市場統計
基準年[2023] 242億美元
預測年份 [2024] 270.1億美元
預測年份 [2030] 537.8億美元
複合年成長率（%） 12.08%

市場動態：揭示快速發展的高通量篩檢市場的關鍵市場洞察

高通量篩檢市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 生技和製藥公司更採用開放式創新模式
    • 增加幹細胞研究中的應用
  • 市場限制因素
    • 設備採購維護高成本
  • 市場機會
    • 製藥公司及政府部門加大研發投入
    • 高通量篩檢技術的進展
  • 市場挑戰
    • 缺乏熟練的操作員和資料解釋的複雜性

波特五力：駕馭高通量篩檢市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解高通量篩檢市場的外部影響

外部宏觀環境因素在塑造高通量篩檢市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解高通量篩檢市場的競爭格局

高通量篩檢市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣高通量篩檢市場供應商績效評估

FPNV定位矩陣是評估高通量篩檢市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了高通量篩檢市場的成功之路

高通量篩檢市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大生技和製藥公司採用開放式創新模式
      • 增加幹細胞研究中的應用
    • 抑制因素
      • 設備採購及維護成本高
    • 機會
      • 製藥業及政府部門加大研發投入
      • 高通量篩檢技術的進步
    • 任務
      • 缺乏熟練的操作員和資料解釋的複雜性
  • 市場區隔分析
    • 產品和服務：在 HTS 流程中使用軟體來管理大量原始資料正在蓬勃發展
    • 技術：採用基於細胞的檢測技術來獲取藥物發現過程的生物學相關資料
    • 篩檢規模：利用96孔盤格式增加以細胞為基礎的研究
    • 應用：高溫超導過程在藥物發現中廣泛使用，以鑑定具有藥理或生物活性的化合物
    • 最終用戶：透過 HTS 技術在製藥和生物技術公司中的滲透，新療法的快速開發
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章高通量篩檢市場：依產品與服務分類

  • 消耗品
    • 實驗設備
    • 試劑和檢測試劑套件
  • 裝置
    • 檢測系統
    • 液體處理系統
  • 服務
  • 軟體

第7章依篩檢尺寸分類的高通量篩檢市場

  • 12孔格式
  • 1536孔格式
  • 24孔格式
  • 384孔格式
  • 48孔格式
  • 6孔格式
  • 96孔盤格式

第8章高通量篩檢市場：依技術分類

  • 基於細胞的檢測
    • 2D細胞培養
    • 3D細胞培養
      • 基於支架的技術
      • 水凝膠
      • 海藻酸鹽和瓊脂糖
      • 動物源性水凝膠
      • 膠原蛋白
      • 基質膠
      • 合成水凝膠
      • 惰性基質和固體支架
      • 微圖案表面
      • 無支架技術
      • 吊掛式滴板
      • 超低結合板
    • 灌流細胞培養
    • 基於報告基因的檢測
  • 實驗室晶片技術
  • 無標定技術

第9章高通量篩檢市場：依應用分類

  • 生化篩檢
  • 藥物發現
  • 生命科學研究

第 10 章 高通量篩檢市場：依最終使用者分類

  • 學術研究所
  • 合約調查機構
  • 製藥和生物技術公司

第11章美洲高通量篩檢市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區高通量篩檢市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東和非洲高通量篩檢市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Axxam 和 Promega 同意開發用於藥物發現服務的智慧檢測方法
    • Charles River Laboratories 收購 SAMDI Tech
    • Particle Works 發布 ALiS，這是一個用於 LNP 配方篩檢的自動化高通量平台
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Aurora Biomed, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biomat Srl
  • BMG Labtech GmbH
  • BRAND GMBH+CO KG
  • Charles River Laboratories
  • Corning Incorporated
  • Creative Biolabs, Inc.
  • Danaher Corporation
  • DIANA Biotechnologies, AS
  • Eppendorf SE
  • Eurofins Scientific
  • Gilson Incorporated
  • Hamilton Company
  • HighRes Biosolutions
  • Lonza Group AG
  • Merck KGaA
  • Mettler Toledo International, Inc.
  • PerkinElmer, Inc.
  • Revvity, Inc.
  • Sartorius AG
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
Product Code: MRR-501246436FA8

The High-Throughput Screening Market was valued at USD 24.20 billion in 2023, expected to reach USD 27.01 billion in 2024, and is projected to grow at a CAGR of 12.08%, to USD 53.78 billion by 2030.

High-Throughput Screening (HTS) is an essential technology in drug discovery and chemical biology that facilitates the rapid testing of thousands to millions of samples for biological activity at a cellular or molecular level. It is primarily used to identify active compounds, antibodies, or genes that modulate a particular biomolecular pathway. The necessity of HTS arises from the increasing demand for efficient drug discovery processes, allowing researchers to quickly identify promising candidates from massive libraries of chemicals and genetic material. HTS finds applications across pharmaceuticals, biotechnology, and academic research institutions, serving end-users like drug developers, biological scientists, and genomic researchers. Market growth is significantly influenced by technological advancements in robotics and data analytics, alongside an increasing focus on personalized medicine and biologics. Key opportunities lie in the growing use of artificial intelligence and machine learning to enhance the data analysis capabilities of HTS, thereby improving predictive accuracy and reducing false positives. Moreover, the miniaturization of assays and increasing automation open further avenues for cost reduction and increased throughput. However, challenges such as the high initial investment required for HTS technology, and the complexity associated with data management and integration, may restrict market growth. Intellectual property issues and regulatory hurdles also present significant barriers. Innovations focusing on integrating bioinformatics with HTS and developing novel assay techniques, particularly in the field of genomics and proteomics, offer fertile ground for business growth. The market is poised to be dynamic and competitive, driven by continual technological advancements. Firms aiming to capture market share should invest in robust data analytics tools and focus on collaborative partnerships to streamline HTS methodologies, ensuring they remain at the forefront in the evolving landscape of drug discovery and personalized medicine.

KEY MARKET STATISTICS
Base Year [2023] USD 24.20 billion
Estimated Year [2024] USD 27.01 billion
Forecast Year [2030] USD 53.78 billion
CAGR (%) 12.08%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving High-Throughput Screening Market

The High-Throughput Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing adoption of open innovation models in biotechnology and pharmaceutical companies
    • Rising applications in stem cell research
  • Market Restraints
    • High cost associated with the equipment procurement and maintenance
  • Market Opportunities
    • Increasing investment in R&D by pharmaceutical & Government authorities
    • Technological advancements high throughput screening
  • Market Challenges
    • Dearth of skilled operators coupled with complexities related to data interpretation

Porter's Five Forces: A Strategic Tool for Navigating the High-Throughput Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the High-Throughput Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the High-Throughput Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the High-Throughput Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the High-Throughput Screening Market

A detailed market share analysis in the High-Throughput Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the High-Throughput Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the High-Throughput Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the High-Throughput Screening Market

A strategic analysis of the High-Throughput Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the High-Throughput Screening Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Aurora Biomed, Inc., Bio-Rad Laboratories, Inc., Biomat S.r.l, BMG Labtech GmbH, BRAND GMBH + CO KG, Charles River Laboratories, Corning Incorporated, Creative Biolabs, Inc., Danaher Corporation, DIANA Biotechnologies, A.S., Eppendorf SE, Eurofins Scientific, Gilson Incorporated, Hamilton Company, HighRes Biosolutions, Lonza Group AG, Merck KGaA, Mettler Toledo International, Inc., PerkinElmer, Inc., Revvity, Inc., Sartorius AG, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the High-Throughput Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Consumables, Instruments, Services, and Software. The Consumables is further studied across Laboratory Equipment and Reagents & Assay Kits. The Instruments is further studied across Detection Systems and Liquid Handling Systems.
  • Based on Screening Size, market is studied across 12-well Format, 1536-well Format, 24-well Format, 384-well Format, 48-well Format, 6-well Format, and 96-well Format.
  • Based on Technology, market is studied across Cell-Based Assays, Lab-on-a-Chip Technology, and Label-Free Technology. The Cell-Based Assays is further studied across 2D Cell Culture, 3D Cell Culture, Perfusion Cell Culture, and Reporter-Based Assays. The 3D Cell Culture is further studied across Scaffold-Based Technology and Scaffold-Free Technology. The Scaffold-Based Technology is further studied across Hydrogels, Inert Matrix & Solid Scaffolds, and Micropatterned Surfaces. The Hydrogels is further studied across Alginate & Agarose, Animal-Derived Hydrogels, and Synthetic Hydrogels. The Animal-Derived Hydrogels is further studied across Collagen and Matrigel. The Scaffold-Free Technology is further studied across Hanging-Drop Plates and Ultra-Low Binding Plates.
  • Based on Application, market is studied across Biochemical Screening, Drug Discovery, and Life Sciences Research.
  • Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing adoption of open innovation models in biotechnology and pharmaceutical companies
      • 5.1.1.2. Rising applications in stem cell research
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the equipment procurement and maintenance
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in R&D by pharmaceutical & Government authorities
      • 5.1.3.2. Technological advancements high throughput screening
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled operators coupled with complexities related to data interpretation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product & Service: Proliferating use of software in the HTS process to manage vast amounts of raw data
    • 5.2.2. Technology: Adoption of cell-based assay technologies to get biologically relevant data for the drug discovery process
    • 5.2.3. Screening Size: Utilization of 96-well format for increase in cell based studies
    • 5.2.4. Application: Extensive utilization of the HTS process in drug discovery to identify compounds with pharmacological or biological activity
    • 5.2.5. End User: Penetration of HTS technology in pharmaceutical & biotechnology companies for rapid development of novel therapeutics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. High-Throughput Screening Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Laboratory Equipment
    • 6.2.2. Reagents & Assay Kits
  • 6.3. Instruments
    • 6.3.1. Detection Systems
    • 6.3.2. Liquid Handling Systems
  • 6.4. Services
  • 6.5. Software

7. High-Throughput Screening Market, by Screening Size

  • 7.1. Introduction
  • 7.2. 12-well Format
  • 7.3. 1536-well Format
  • 7.4. 24-well Format
  • 7.5. 384-well Format
  • 7.6. 48-well Format
  • 7.7. 6-well Format
  • 7.8. 96-well Format

8. High-Throughput Screening Market, by Technology

  • 8.1. Introduction
  • 8.2. Cell-Based Assays
    • 8.2.1. 2D Cell Culture
    • 8.2.2. 3D Cell Culture
      • 8.2.2.1. Scaffold-Based Technology
      • 8.2.2.1.1. Hydrogels
      • 8.2.2.1.1.1. Alginate & Agarose
      • 8.2.2.1.1.2. Animal-Derived Hydrogels
      • 8.2.2.1.1.2.1. Collagen
      • 8.2.2.1.1.2.2. Matrigel
      • 8.2.2.1.1.3. Synthetic Hydrogels
      • 8.2.2.1.2. Inert Matrix & Solid Scaffolds
      • 8.2.2.1.3. Micropatterned Surfaces
      • 8.2.2.2. Scaffold-Free Technology
      • 8.2.2.2.1. Hanging-Drop Plates
      • 8.2.2.2.2. Ultra-Low Binding Plates
    • 8.2.3. Perfusion Cell Culture
    • 8.2.4. Reporter-Based Assays
  • 8.3. Lab-on-a-Chip Technology
  • 8.4. Label-Free Technology

9. High-Throughput Screening Market, by Application

  • 9.1. Introduction
  • 9.2. Biochemical Screening
  • 9.3. Drug Discovery
  • 9.4. Life Sciences Research

10. High-Throughput Screening Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas High-Throughput Screening Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific High-Throughput Screening Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa High-Throughput Screening Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Axxam And Promega Announce Agreement To Develop Smart Assays For Drug Discovery Services
    • 14.3.2. Charles River Laboratories Acquires SAMDI Tech
    • 14.3.3. Particle Works Launches ALiS - An Automated and High-Throughput Platform for LNP Formulation Screening
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Aurora Biomed, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Biomat S.r.l
  • 5. BMG Labtech GmbH
  • 6. BRAND GMBH + CO KG
  • 7. Charles River Laboratories
  • 8. Corning Incorporated
  • 9. Creative Biolabs, Inc.
  • 10. Danaher Corporation
  • 11. DIANA Biotechnologies, A.S.
  • 12. Eppendorf SE
  • 13. Eurofins Scientific
  • 14. Gilson Incorporated
  • 15. Hamilton Company
  • 16. HighRes Biosolutions
  • 17. Lonza Group AG
  • 18. Merck KGaA
  • 19. Mettler Toledo International, Inc.
  • 20. PerkinElmer, Inc.
  • 21. Revvity, Inc.
  • 22. Sartorius AG
  • 23. Tecan Group Ltd.
  • 24. Thermo Fisher Scientific Inc.
  • 25. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. HIGH-THROUGHPUT SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. HIGH-THROUGHPUT SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. HIGH-THROUGHPUT SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. HIGH-THROUGHPUT SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HIGH-THROUGHPUT SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HIGH-THROUGHPUT SCREENING MARKET DYNAMICS
  • TABLE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABORATORY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 12-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 24-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 48-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 6-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL FORMAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 2D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ALGINATE & AGAROSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MATRIGEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SYNTHETIC HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INERT MATRIX & SOLID SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROPATTERNED SURFACES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HANGING-DROP PLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ULTRA-LOW BINDING PLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PERFUSION CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY BIOCHEMICAL SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIFE SCIENCES RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 181. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 182. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. INDIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 196. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. INDONESIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 207. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 209. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 210. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 212. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. JAPAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 220. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 221. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 222. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 223. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 225. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 228. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. MALAYSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 234. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 236. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 238. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 242. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. PHILIPPINES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 246. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 247. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 248. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 249. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 250. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 251. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 252. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 254. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 255. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 256. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SINGAPORE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 260. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 261. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 262. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 264. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 265. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 266. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 268. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. SOUTH KOREA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 272. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 273. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 274. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 275. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 276. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 277. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 278. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 280. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 281. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. TAIWAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 285. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 286. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 287. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 288. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 289. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 290. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 291. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 292. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 293. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 294. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 296. THAILAND HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 297. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 298. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 299. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 300. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 301. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 303. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 304. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 306. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2030 (USD MILLION)
  • TABLE 307. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 308. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. VIETNAM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2030 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)